T. M. Ross

This study tracks antibody levels and memory B cell recall after SARS-CoV-2 infection or vaccination, finding that antibody waning occurs faster after vaccination than infection and that memory B cell recall can occur without detectable antibodies.

This study identifies pre-existing human B cell responses to computationally optimized H1 hemagglutinin vaccines, showing cross-reactivity and functional antibodies targeting head, central stalk, and anchor epitopes.

This study demonstrates that thin-film freeze-drying can convert MF59 or AddaVax-adjuvanted vaccines into dry powders while preserving immunogenicity and stability.

This study compares antibody responses to SARS-CoV-2 vaccination in pre-immune and immunologically naive individuals, finding higher neutralizing antibody levels in pre-immune participants.

This study tests broadly reactive H2 HA vaccines in pre-immune ferrets, showing that pre-existing immunity enhances cross-reactive antibody responses and protection against swine H2N3 influenza.

This study evaluates antigenic differences among H7 influenza HA proteins by vaccinating mice with VLPs and identifies key mutations affecting vaccine efficacy.

This study shows that neutralizing antibodies against SARS-CoV-2 need intact Fc functions and monocytes for optimal therapeutic protection in animal models.